"The third edition of this textbook, now titled Tumor Board Review: Evidence-Based Case Reviews and Questions, includes recent advances in the diagnosis and treatment of the most common malignancies encountered by oncology providers. The text includes recently published clinical studies and updated cancer guidelines, as well as discussions of the importance of genetic mutations in selection of anticancer drugs based on phase III clinical trials in both solid tumors and hematological malignancies. The text uses a case-based format with each oncologic disease type presented in a tumor board format with a brief synopsis of a patient case followed by a discussion of the imaging and molecular and/or genomic sequencing required for a correct diagnosis. Each chapter concludes with a dialogue on staging and treatment including chemotherapy, immunotherapy, and targeted agent regimens, as well as pertinent information related to follow-up and survivorship. Board-style questions are included at the end of each chapter to help the reader enhance their knowledge base. The content of this third edition represents an effort to incorporate and highlight the most recent clinically relevant data in the field, and the book continues to represent a joint effort between oncology faculty and subspecialty fellows based at the Baylor College of Medicine (Houston, Texas), the University of Michigan Medical School (Ann Arbor, Michigan), and the University of California Davis Medical Center (Sacramento, California)"--